AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab - Scorecard - MDSpire

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

  • By

  • Wanying Qin

  • Xudong Fei

  • Renfang Shi

  • Yuchen Zhou

  • Jiajie Tang

  • Yizhe Liu

  • Yi Zhu

  • Liya Suo

  • Weijia Liao

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Prognostic Value of AAT Score from Pre-Treatment Factors in Patients with Unresectable Hepatocellular Carcinoma Undergoing TACE, Sintilimab, and Bevacizumab Therapy

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with intermediate-advanced stage unresectable HCC
Care Setting

Key Highlights

  • additional_info

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • S
      • p
      • e
      • c
      • i
      • f
      • y
      • m
      • e
      • t
      • r
      • i
      • c
      • s
      • a
      • n
      • d
      • t
      • i
      • m
      • e
      • l
      • i
      • n
      • e
      • s
      • f
      • o
      • r
      • t
      • r
      • e
      • a
      • t
      • m
      • e
      • n
      • t
      • r
      • e
      • s
      • p
      • o
      • n
      • s
      • e
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • .

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • examples

        Related Resources & Content

        Original Source(s)

        AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

        • by Wanying Qin, Xudong Fei, Renfang Shi, Yuchen Zhou, Jiajie Tang, Yizhe Liu, Yi Zhu, Liya Suo, Weijia Liao

        • June 10, 2026

        Related Content

        Ensemble based in transfer learning for cytological classification in pleural fluid

        Angiosarcoma in a soft tissue sarcoma cohort: real-world patterns and outcomes

        Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition